1. Home
  2. TNGX vs CCSI Comparison

TNGX vs CCSI Comparison

Compare TNGX & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • CCSI
  • Stock Information
  • Founded
  • TNGX 2014
  • CCSI 2021
  • Country
  • TNGX United States
  • CCSI United States
  • Employees
  • TNGX N/A
  • CCSI N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • CCSI Retail: Computer Software & Peripheral Equipment
  • Sector
  • TNGX Health Care
  • CCSI Technology
  • Exchange
  • TNGX Nasdaq
  • CCSI Nasdaq
  • Market Cap
  • TNGX 413.6M
  • CCSI 483.6M
  • IPO Year
  • TNGX N/A
  • CCSI N/A
  • Fundamental
  • Price
  • TNGX $3.92
  • CCSI $24.49
  • Analyst Decision
  • TNGX Strong Buy
  • CCSI Hold
  • Analyst Count
  • TNGX 8
  • CCSI 5
  • Target Price
  • TNGX $13.14
  • CCSI $26.00
  • AVG Volume (30 Days)
  • TNGX 3.5M
  • CCSI 140.9K
  • Earning Date
  • TNGX 11-06-2024
  • CCSI 11-07-2024
  • Dividend Yield
  • TNGX N/A
  • CCSI N/A
  • EPS Growth
  • TNGX N/A
  • CCSI 16.33
  • EPS
  • TNGX N/A
  • CCSI 4.56
  • Revenue
  • TNGX $43,383,000.00
  • CCSI $351,153,000.00
  • Revenue This Year
  • TNGX $25.55
  • CCSI N/A
  • Revenue Next Year
  • TNGX N/A
  • CCSI N/A
  • P/E Ratio
  • TNGX N/A
  • CCSI $5.37
  • Revenue Growth
  • TNGX 15.67
  • CCSI N/A
  • 52 Week Low
  • TNGX $2.70
  • CCSI $11.62
  • 52 Week High
  • TNGX $13.01
  • CCSI $28.10
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 39.26
  • CCSI 55.89
  • Support Level
  • TNGX $3.54
  • CCSI $23.05
  • Resistance Level
  • TNGX $4.22
  • CCSI $25.91
  • Average True Range (ATR)
  • TNGX 0.53
  • CCSI 1.21
  • MACD
  • TNGX 0.13
  • CCSI -0.15
  • Stochastic Oscillator
  • TNGX 48.61
  • CCSI 30.38

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

Share on Social Networks: